Unité de Fabrication des Médicaments S.A (BVMT: UMED)

UMED Income Statement

Financials in millions TND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	136	136	96.36	84.5	91.04	107.21
Other Revenue	-	-	-	0.01	-	-
Revenue	136	136	96.36	84.51	91.04	107.21
Revenue Growth (YoY)	41.14%	41.14%	14.02%	-7.18%	-15.07%	23.10%
Cost of Revenue	61.72	61.72	46.8	38.22	43.69	48.54
Gross Profit	74.29	74.29	49.56	46.29	47.35	58.67
Selling, General & Admin	19.71	19.71	16.77	15.48	15.1	14.99
Other Operating Expenses	9.88	9.88	8.27	6.87	8.37	7.72
Operating Expenses	45.18	45.18	35.95	32.55	34.03	29.86
Operating Income	29.11	29.11	13.61	13.74	13.33	28.8
Interest Expense	-6.22	-6.22	-3.6	-2.63	-3.74	-3.93
Interest & Investment Income	0.09	0.09	0.19	0.28	0.01	0.01
Currency Exchange Gain (Loss)	-0.48	-0.48	-0.05	-0.48	0.33	-1.73
Other Non Operating Income (Expenses)	-11.3	-11.3	-0.22	-0.45	-0.69	-1.07
EBT Excluding Unusual Items	11.21	11.21	9.94	10.47	9.23	22.08
Gain (Loss) on Sale of Assets	0.08	0.08	0.09	0.04	0.08	0.03
Asset Writedown	-0.3	-0.3	-0.2	-0.08	-0.04	-0.01
Pretax Income	10.99	10.99	9.83	10.43	9.27	22.09
Income Tax Expense	5.45	5.45	2	1.72	2.29	4.4
Earnings From Continuing Operations	5.55	5.55	7.83	8.7	6.98	17.69
Net Income	5.55	5.55	7.83	8.7	6.98	17.69
Net Income to Common	5.55	5.55	7.83	8.7	6.98	17.69
Net Income Growth	-29.17%	-29.17%	-10.03%	24.69%	-60.55%	-3.64%
Shares Outstanding (Basic)	32	32	32	32	32	32
Shares Outstanding (Diluted)	32	32	32	32	32	32
EPS (Basic)	0.17	0.17	0.24	0.27	0.22	0.55
EPS (Diluted)	0.17	0.17	0.24	0.27	0.22	0.55
EPS Growth	-29.17%	-29.17%	-10.03%	24.69%	-60.55%	-3.64%
Free Cash Flow	18.68	18.68	-12.07	15.13	0.08	-3.48
Free Cash Flow Per Share	0.58	0.58	-0.38	0.47	0.00	-0.11
Dividend Per Share	-	-	0.469	0.406	-	-
Dividend Growth	-	-	15.52%	-	-	-
Gross Margin	54.62%	54.62%	51.43%	54.78%	52.01%	54.72%
Operating Margin	21.40%	21.40%	14.12%	16.26%	14.64%	26.87%
Profit Margin	4.08%	4.08%	8.13%	10.30%	7.67%	16.50%
Free Cash Flow Margin	13.73%	13.73%	-12.52%	17.90%	0.09%	-3.24%
EBITDA	39.11	39.11	23.3	23.02	22.79	35.8
EBITDA Margin	28.75%	28.75%	24.18%	27.24%	25.03%	33.39%
D&A For EBITDA	10	10	9.69	9.27	9.46	7
EBIT	29.11	29.11	13.61	13.74	13.33	28.8
EBIT Margin	21.40%	21.40%	14.12%	16.26%	14.64%	26.87%
Effective Tax Rate	49.56%	49.56%	20.35%	16.52%	24.74%	19.92%
Revenue as Reported	136.15	136.15	96.62	84.55	91.07	107.25

Source: S&P Capital IQ. Standard template. Financial Sources.